Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marina Aloi

Showing results (81-90 of 149) with videos related to

Pageof 15
Sort By:
Inflammatory Bowel Diseases|March 16, 2017
Multicentric Case-Control Study on Azathioprine Dose and Pharmacokinetics in Early-onset Pediatric Inflammatory Bowel DiseaseGabriele Stocco, Stefano Martelossi, Serena Arrigo, et al.
The Lancet. Gastroenterology & Hepatology|January 9, 2025
Maintenance treatment with vedolizumab in paediatric inflammatory bowel disease (VEDOKIDS): 54-week outcomes of a multicentre, prospective, cohort studyOhad Atia, Zivia Shavit-Brunschwig, Raffi Lev-Tzion, et al.
United European Gastroenterology Journal|July 19, 2019
Efficacy and safety of infliximab in very early onset inflammatory bowel disease: a national comparative retrospective studyMatteo Bramuzzo, Serena Arrigo, Claudio Romano, et al.
Journal of Pediatric Gastroenterology and Nutrition|January 13, 2016
Clinical Features and Risk Factors of Autoimmune Liver Involvement in Pediatric Inflammatory Bowel DiseaseMatteo Bramuzzo, Stefano Martelossi, Giuliano Torre, et al.
Scientific Reports|September 11, 2021
Factors associated with quality of life in Italian children and adolescents with IBDSimona Gatti, Giada Del Baldo, Giulia Catassi, et al.
Journal of Pediatric Gastroenterology and Nutrition|January 10, 2018
Efficacy and Safety of Adalimumab in Pediatric Ulcerative Colitis: A Real-life Experience from the SIGENP-IBD RegistryMarina Aloi, Matteo Bramuzzo, Serena Arrigo, et al.
Children (Basel, Switzerland)|October 23, 2021
Atopic Manifestations in Children Born Preterm: A Long-Term Observational StudyFederica Pagano, Maria Giulia Conti, Giovanni Boscarino, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 8, 2019
Primary Sclerosing Cholangitis in Children With Inflammatory Bowel Diseases Is Associated With Milder Clinical Activity But More Frequent Subclinical Inflammation and Growth ImpairmentAmanda Ricciuto, Bettina E Hansen, Brian Ngo, et al.
The Lancet. Gastroenterology & Hepatology|October 28, 2022
Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS): a prospective, multicentre cohort studyOhad Atia, Zivia Shavit-Brunschwig, Diane R Mould, et al.
Biologics : Targets & Therapy|January 19, 2019
Efficacy of adalimumab as second-line therapy in a pediatric cohort of Crohn's disease patients who failed infliximab therapy: the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition experiencePatrizia Alvisi, Serena Arrigo, Salvatore Cucchiara, et al.
Pageof 15

Showing results (81-90 of 149) with videos related to

Sort By:
Pageof 15
Inflammatory Bowel Diseases|March 16, 2017
Multicentric Case-Control Study on Azathioprine Dose and Pharmacokinetics in Early-onset Pediatric Inflammatory Bowel DiseaseGabriele Stocco, Stefano Martelossi, Serena Arrigo, et al.
The Lancet. Gastroenterology & Hepatology|January 9, 2025
Maintenance treatment with vedolizumab in paediatric inflammatory bowel disease (VEDOKIDS): 54-week outcomes of a multicentre, prospective, cohort studyOhad Atia, Zivia Shavit-Brunschwig, Raffi Lev-Tzion, et al.
United European Gastroenterology Journal|July 19, 2019
Efficacy and safety of infliximab in very early onset inflammatory bowel disease: a national comparative retrospective studyMatteo Bramuzzo, Serena Arrigo, Claudio Romano, et al.
Journal of Pediatric Gastroenterology and Nutrition|January 13, 2016
Clinical Features and Risk Factors of Autoimmune Liver Involvement in Pediatric Inflammatory Bowel DiseaseMatteo Bramuzzo, Stefano Martelossi, Giuliano Torre, et al.
Scientific Reports|September 11, 2021
Factors associated with quality of life in Italian children and adolescents with IBDSimona Gatti, Giada Del Baldo, Giulia Catassi, et al.
Journal of Pediatric Gastroenterology and Nutrition|January 10, 2018
Efficacy and Safety of Adalimumab in Pediatric Ulcerative Colitis: A Real-life Experience from the SIGENP-IBD RegistryMarina Aloi, Matteo Bramuzzo, Serena Arrigo, et al.
Children (Basel, Switzerland)|October 23, 2021
Atopic Manifestations in Children Born Preterm: A Long-Term Observational StudyFederica Pagano, Maria Giulia Conti, Giovanni Boscarino, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 8, 2019
Primary Sclerosing Cholangitis in Children With Inflammatory Bowel Diseases Is Associated With Milder Clinical Activity But More Frequent Subclinical Inflammation and Growth ImpairmentAmanda Ricciuto, Bettina E Hansen, Brian Ngo, et al.
The Lancet. Gastroenterology & Hepatology|October 28, 2022
Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS): a prospective, multicentre cohort studyOhad Atia, Zivia Shavit-Brunschwig, Diane R Mould, et al.
Biologics : Targets & Therapy|January 19, 2019
Efficacy of adalimumab as second-line therapy in a pediatric cohort of Crohn's disease patients who failed infliximab therapy: the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition experiencePatrizia Alvisi, Serena Arrigo, Salvatore Cucchiara, et al.
Pageof 15